Allergy

The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.

Tezepelumab Improves Severe Asthma Exacerbation, Disease Control in Phase 3 NAVIGATOR

May 12, 2021

Article

The newest findings show the TSLP inhibitor is beneficial over 52 weeks in patients aged 12-80 years old.

Benefits of Immunotherapy Treatment for Children with Ragweed Allergies

April 27, 2021

Video

David I. Bernstein, MD of the University of Cincinnati College of Medicine discusses the recent approval of short ragweed pollen allergen extract tablet (RAGWITEK) for the treatment of children and adolescents.

Dupilumab Sustains Pediatric Atopic Dermatitis Improvement at 52 Weeks

April 23, 2021

Article

Phase 3 open-label extension data suggest young patients may even improve skin clearance scores after a year on the biologic therapy.

Food Allergy and Anaphylaxis: Promoting Awareness and Understanding

April 21, 2021

Article

An expert writes on the value of shared knowledge into the intricacies of allergic risks.

Oral Corticosteroid Burst Increases Adverse Event Risk in Children

April 20, 2021

Article

Recent data finds children treated for allergies with ≥14 consecutive days of corticosteroids experienced greater incidence rates than those not treated with a corticosteroid.

Add-On Mepolizumab Promising Option for Chronic Rhinosinusitis with Nasal Polyps

April 20, 2021

Article

The monoclonal antibody was linked to significant improvements in endoscopic nasal polyp and nasal obstruction symptom visual analogue scale scores.

FDA Approves RAGWITEK for Children, Adolescents with Ragweed Allergies

April 19, 2021

Article

The approval expands the current sublingual tablet treatment indications to include children with a ragweed pollen allergy.

FDA Allows for Omalizumab Self-Injection Across All Indications

April 12, 2021

Article

The approval of the sBLA means greater flexibility and reduced barriers in care during the pandemic.

Chronic Rhinosinusitis May Alter Functional Brain Connectivity

April 08, 2021

Article

fMRI imaging shows decreased functional connectivity within the frontoparietal network of affected patients.

FDA Expands Use of Sinus Treatment to Include Congestion from Allergies, Influenza

March 24, 2021

Article

ClearUp Sinus Pain Relief treatment was previously approved for allergy-related sinus and nasal congestion and allergy-related sinus pain.